On March 24, 2020, the U.S. Food and Drug Administration (FDA) began allowing researchers to request emergency authorization for the use of convalescent plasma, which shows potential as a treatment for COVID-19. We are following a research protocol from the Mayo Clinic to take “convalescent plasma,” or plasma obtained from those who have recovered from COVID-19, and administer it to hospitalized patients infected with the novel coronavirus who have severe or life-threatening symptoms, or who may be at high risk for progression to severe or life-threatening disease.
As part of the Mayo Clinic protocol, UC and UC Health will be working with Cincinnati’s Hoxworth Blood Center to obtain the convalescent plasma from eligible donors. Hoxworth Center is seeking individuals who:
Have recovered from a documented infection of COVID-19 and have been symptom-free for at least 28 days.
Believe they had COVID-19. The product will be tested for antibodies following donation. If your plasma does not contain high levels of antibodies to COVID-19, it may be used to help save the lives of other patients.
If you tested positive for COVID-19, or believe you had COVID-19, and have been fully recovered for at least 28 days, please click here to fill out the eligibility form and get scheduled for a donation today. Appointments are required for donation.